METHODS	A total of 328 ASA I-III patients were randomized to one of four groups to receive Diprivan propofol ( Group DP ) , Lipuro propofol ( Group LP ) , Diprivan with lidocaine ( Group DL ) and Lipuro propofol with lidocaine ( Group LL ) .\